World ADC San Diego 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Pfizer at World ADC San Diego 2026

Oct 12–15, 2026 San Diego, CA ~1.3k attendees Website

Pfizer takes part in 7 sessions at World ADC San Diego 2026 in San Diego. Its sessions focus on new ADC payloads and combination treatments. They include PF-08046033, a GPNMB-targeted ADC whose payload was modified to be better tolerated, a payload that blocks protein production in cells, and combination partners for vedotin ADCs such as PADCEV.

Organization	World ADC San Diego 2026 Attendance
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company whose oncology portfolio includes ADCs gained with Seagen, such as PADCEV.	Panel Tue Oct 13 8:00am Contextualizing the Current Status of Novel ADC Design & Development to Ensure Future ADC Success & Differentiated Patient Impact Plenary · with Amgen, Daiichi Sankyo, Iksuda Therapeutics +1 more ADC discovery chemistryADC discovery biology Talk Tue Oct 13 11:00am PF-08046033: Advancing GPNMB Targeted Auristatin-S ADC Through Payload Modification to Improve Tolerability Preclinical Talk Tue Oct 13 12:00pm Deep-Diving Into Mechanistic Insights of a Novel ADC Payload That Inhibits Protein Translation Discovery Chemistry Talk Tue Oct 13 2:00pm Setting the Scene for Novel Combination Partner Approaches for Vedotin-Based ADCs Including PADCEV – VIRTUAL PRESENTATION Clinical Lessons Panel Tue Oct 13 3:30pm What’s the New Path to the Next Generation of ADCs? Discovery Biology · with Sygnature Discovery, AstraZeneca, Iksuda Therapeutics +1 more Chair Leveraging Novel Payload MoAs & Combinations to Differentiate ADC Mechanisms & Combat Patient Resistance Discovery Chemistry Panel Wed Oct 14 2:30pm What is Showing the Most Promise & What Still Needs to be Proven in ADC Chemistry & Mechanistic Innovation? Discovery Chemistry

Organization

World ADC San Diego 2026 Attendance

Pfizer

New York, NY

pfizer.com

Large pharma

Global pharmaceutical company whose oncology portfolio includes ADCs gained with Seagen, such as PADCEV.

Panel

Tue Oct 13
8:00am

Contextualizing the Current Status of Novel ADC Design & Development to Ensure Future ADC Success & Differentiated Patient Impact

Plenary · with Amgen, Daiichi Sankyo, Iksuda Therapeutics +1 more

ADC discovery chemistryADC discovery biology

Talk

Tue Oct 13
11:00am

PF-08046033: Advancing GPNMB Targeted Auristatin-S ADC Through Payload Modification to Improve Tolerability

Preclinical

Talk

Tue Oct 13
12:00pm

Deep-Diving Into Mechanistic Insights of a Novel ADC Payload That Inhibits Protein Translation

Discovery Chemistry

Talk

Tue Oct 13
2:00pm

Setting the Scene for Novel Combination Partner Approaches for Vedotin-Based ADCs Including PADCEV – VIRTUAL PRESENTATION

Clinical Lessons

Panel

Tue Oct 13
3:30pm

What’s the New Path to the Next Generation of ADCs?

Discovery Biology · with Sygnature Discovery, AstraZeneca, Iksuda Therapeutics +1 more

Chair

Leveraging Novel Payload MoAs & Combinations to Differentiate ADC Mechanisms & Combat Patient Resistance

Discovery Chemistry

Panel

Wed Oct 14
2:30pm

What is Showing the Most Promise & What Still Needs to be Proven in ADC Chemistry & Mechanistic Innovation?

Discovery Chemistry

Instantly find 20 buyers from Pfizer

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World ADC or its organizers. Submit a correction